Highlighting key issues and differences among GMPs of Europe, Canada, and the WHO, this reference examines US law and governmental policy affecting domestic and multinational pharmaceutical manufacturing. The book recommend pragmatic ways to interpret and comply with FDA CGMP regulation and related criteria. They focus on geographical redistribution of manufacturing facilities, accommodation of a diversity of regulatory and statutory governance, adaptation to disparate human resources, and new growth areas of manufacture and distribution of homeopathic remedies and dietary supplements, in addition to the greater quality control required of pharmacists and other authorized dispensers.
FREE Two-Day Shipping for students on millions of items. Learn more |
| ||||||||||||
 Sell Back Your Copy for $15.47
Whether you buy it used on Amazon for $39.99 or somewhere else, you can sell it back through our Book Trade-In Program at the current price of $15.47.
Used Price$39.99
Trade-in Price$15.47
Price after
Trade-in$24.52 |
|
There is a newer edition of this item:
|
Book Description
Product Details
Would you like to update product info or give feedback on images?
|
More About the Author
Discover books, learn about writers, read author blogs, and more.
Customer Reviews
|
Share your thoughts with other customers:
|
||||||||||||||||||||||
|
Most Helpful Customer Reviews
1 of 23 people found the following review helpful:
5.0 out of 5 stars
Family,
By A Customer
This review is from: Good Manufacturing Practices for Pharmaceuticals: A Plan for Total Quality Control from Manufacturer (Drugs and the Pharmaceutical Sciences) (Hardcover)
This was written by my Great Uncle. He was a great man and a distinguised professional. He was the authority on Pharmaceutical Law, hence this is essentially a manual.
Share your thoughts with other customers: Create your own review
|
|
Inside This Book
(learn more)
First Sentence:
This chapter addresses FDA and some other federal regulations that have been promulgated for statutory effectuation and implementation in the main. Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
authorizing civil money penalties, reserve sample retention, dose tissue distribution studies, draft tripartite guideline entitled, radiopharmaceutical drug products, homeopathic drug products, high dose selection, nonclinical toxicity studies, relative systemic exposure ratio, initiating regulatory action, draft guideline entitled, drug product containers, leaving visible evidence, reserve samples, opportunity for tripartite harmonization initiatives, food contact substance, concomitant toxicokinetics, maximum feasible dose, liquid oral dosage forms, managed review process, contract sterilizer, recalling firm, reviewing chemists, single major incident, specific bioavailability Key Phrases - Capitalized Phrases (CAPs): (learn more)
United States, Cosmetic Act, Federal Food, Federal Register, Regulatory Action Guidance, Barr Laboratories, Supreme Court, Judge Wolin, Customs Service, National Confectioners, New York, Computerized Drug Processing, European Union, International Conference, Office of Compliance, Secretary of the Treasury, World Health Organization, Code of Federal Regulations, Draft Guideline, Drug Enforcement Administration, European Economic Community, Fourth Amendment, Government Printing Office, Computer System Validation-Staying Current, Epoxy Epoxy New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Surprise Me!
This chapter addresses FDA and some other federal regulations that have been promulgated for statutory effectuation and implementation in the main. Read the first page Key Phrases - Statistically Improbable Phrases (SIPs): (learn more)
authorizing civil money penalties, reserve sample retention, dose tissue distribution studies, draft tripartite guideline entitled, radiopharmaceutical drug products, homeopathic drug products, high dose selection, nonclinical toxicity studies, relative systemic exposure ratio, initiating regulatory action, draft guideline entitled, drug product containers, leaving visible evidence, reserve samples, opportunity for tripartite harmonization initiatives, food contact substance, concomitant toxicokinetics, maximum feasible dose, liquid oral dosage forms, managed review process, contract sterilizer, recalling firm, reviewing chemists, single major incident, specific bioavailability Key Phrases - Capitalized Phrases (CAPs): (learn more)
United States, Cosmetic Act, Federal Food, Federal Register, Regulatory Action Guidance, Barr Laboratories, Supreme Court, Judge Wolin, Customs Service, National Confectioners, New York, Computerized Drug Processing, European Union, International Conference, Office of Compliance, Secretary of the Treasury, World Health Organization, Code of Federal Regulations, Draft Guideline, Drug Enforcement Administration, European Economic Community, Fourth Amendment, Government Printing Office, Computer System Validation-Staying Current, Epoxy Epoxy New!
Books on Related Topics | Concordance | Text Stats Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Surprise Me!
Citations (learn more)
This book cites 84
books:
See all 84 books this book cites
33
books
cite this book:
See all 33 books citing this book
- Civil Procedure by EZ Rules on 7 pages
- Good Manufacturing Practices for Pharmaceuticals: A Plan for Total Quality Control (Drugs and the Pharmaceutical Sciences Series, Vol 78) by Sidney H. Willig on 4 pages
- New Drug Approval Process, Fourth Edition, Accelerating Global Registrations (Drugs and the Pharmaceutical Sciences) by Richard Guarino in Front Matter (1), Front Matter (2), and Front Matter (3)
- Drug Stability: Principles and Practices (Drugs and the Pharmaceutical Sciences) by Jens T. Carstensen in Front Matter (1), Front Matter (2), and Front Matter (3)
- Modern Pharmaceutics by Gilbert S. Banker in Front Matter (1), Front Matter (2), and Front Matter (3)
See all 84 books this book cites
- Pharmaceutical Extrusion Technology (Drugs and the Pharmaceutical Sciences) by Isaac Ghebre-Selassie in Front Matter
- Surfactants and Polymers in Drug Delivery (Drugs and the Pharmaceutical Sciences) by Martin Malmsten in Front Matter
- Handbook of Pharmaceutical Analysis (Drugs and the Pharmaceutical Sciences) by Lena Ohannesian in Front Matter
- Drug Products for Clinical Trials, Second Edition (Drugs and the Pharmaceutical Sciences) by Donald Monkhouse in Front Matter
- Biomarkers in Clinical Drug Development (Drugs and the Pharmaceutical Sciences) by John Bloom in Front Matter
See all 33 books citing this book
Books on Related Topics
(learn more)
|
|
What Other Items Do Customers Buy After Viewing This Item?
Tags Customers Associate with This Product(What's this?)Click on a tag to find related items, discussions, and people.
|
Sell a Digital Version of This Book in the Kindle Store
If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store.
Learn more
Customer Discussions
|
This product's forum
Active discussions in related forums
Search Customer Discussions
|
Related forums
|
Listmania!
|
|
So You'd Like to...
Look for Similar Items by Category
- Books > Business & Investing > Industries & Professions > Industrial Relations
- Books > Business & Investing > Management & Leadership > Total Quality Management
- Books > Medical Books > Medicine > Internal Medicine
- Books > Medical Books > Pharmacology > Pharmacy
- Books > New & Used Textbooks > Business & Finance
- Books > New & Used Textbooks > Engineering > Chemical Engineering
- Books > New & Used Textbooks > Medicine & Health Sciences > Allied Health Services > Pharmacy
- Books > New & Used Textbooks > Medicine & Health Sciences > Medicine > Basic Sciences > Pharmacology
- Books > Professional & Technical > Engineering
